DURECT Corporation (DRRX)
NASDAQ: DRRX · Real-Time Price · USD
0.950
+0.092 (10.72%)
Dec 20, 2024, 4:00 PM EST - Market closed
DURECT Employees
DURECT had 58 employees as of December 31, 2023. The number of employees decreased by 21 or -26.58% compared to the previous year.
Employees
58
Change (1Y)
-21
Growth (1Y)
-26.58%
Revenue / Employee
$148,172
Profits / Employee
-$294,293
Market Cap
29.49M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Nortech Systems | 775 |
Accelerate Diagnostics | 134 |
RAPT Therapeutics | 131 |
Beyond Air | 107 |
IGC Pharma | 67 |
Incannex Healthcare | 9 |
RenovoRx | 8 |
ProMIS Neurosciences | 7 |
DRRX News
- 26 days ago - DURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 Million - PRNewsWire
- 5 weeks ago - DURECT Corporation (DRRX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - DURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update - PRNewsWire
- 6 weeks ago - DURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business Update - PRNewsWire
- 2 months ago - DURECT Corporation to Present Data on Larsucosterol at The Liver Meeting 2024 - PRNewsWire
- 3 months ago - DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated Hepatitis - PRNewsWire
- 3 months ago - DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference - PRNewsWire
- 4 months ago - DURECT Corporation (DRRX) Q2 2024 Earnings Call Transcript - Seeking Alpha